UnknownPHASE1, PHASE2NCT04141163

Metformin in Patients With Fragile X

Studying Fragile X syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Rowan University
Principal Investigator
Sean McBride, MD, PhD
Rowan University
Intervention
Metformin(drug)
Enrollment
40 enrolled
Eligibility
18-50 years · MALE
Timeline
20192021

Study locations (1)

Collaborators

FRAXA Research Foundation · University of Pennsylvania

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04141163 on ClinicalTrials.gov

Other trials for Fragile X syndrome

Additional recruiting or active studies for the same condition.

See all trials for Fragile X syndrome

← Back to all trials